Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beige

Showing results (121-130 of 195) with videos related to

Pageof 20
Sort By:
Frontiers in Immunology|May 14, 2021
Construction and Validation of an Immune Infiltration-Related Gene Signature for the Prediction of Prognosis and Therapeutic Response in Breast CancerYang Peng, Haochen Yu, Yudi Jin, et al.
Oncology Reports|July 23, 2021
[Corrigendum] HORMAD1 promotes docetaxel resistance in triple negative breast cancer by enhancing DNA damage toleranceBeige Zong, Lu Sun, Yang Peng, et al.
Frontiers in Medicine|January 22, 2024
A case report of a giant ileocecal cystic prolapse through the anus and literature reviewBeige Zong, Xia Xiao, Nijiao Deng, et al.
Clinical Nephrology|November 9, 2017
Endemic influences of political regimes, healthcare systems, and preferences on the frequencies and incidences of nephropathies in eastern Saxony, Germany
Sam Sedaghat, Eleène Sahmila Heshmati, Thomas Frese, et al.
International Journal of Oncology|April 23, 2020
Although c‑MYC contributes to tamoxifen resistance, it improves cisplatin sensitivity in ER‑positive breast cancerRui Chen, Shipeng Guo, Chengcheng Yang, et al.
Oncology Reports|May 26, 2021
HORMAD1 promotes docetaxel resistance in triple negative breast cancer by enhancing DNA damage toleranceBeige Zong, Lu Sun, Yang Peng, et al.
Journal of the American Society of Nephrology : JASN|July 1, 2024
Dialysate Sodium and Mortality: 140 mmol/L at Hemodialysis Initiation by Default?Manfred Hecking, Angelo Karaboyas, Simon Krenn, et al.
Anticancer Research|December 1, 2022
Efficacy of Chemotherapy Plus Bevacizumab in Recurrent Glioblastoma Multiform: A Real-life StudyAlexandre Beige, François Ghiringhelli, Julie Lecuelle, et al.
Archives of Iranian Medicine|July 1, 2021
Efficacy and Safety of Tofacitinib for Treatment of Moderate to Severe Active Ulcerative Colitis: First Report from IranMaryam Jameshorani, Homayoon Vahedi, Anahita Sadeghi, et al.
Cancer Biology & Therapy|November 6, 2019
Low pretreatment lymphocyte/monocyte ratio is associated with the better efficacy of neoadjuvant chemotherapy in breast cancer patientsYang Peng, Rui Chen, Fanli Qu, et al.
Pageof 20

Showing results (121-130 of 195) with videos related to

Sort By:
Pageof 20
Frontiers in Immunology|May 14, 2021
Construction and Validation of an Immune Infiltration-Related Gene Signature for the Prediction of Prognosis and Therapeutic Response in Breast CancerYang Peng, Haochen Yu, Yudi Jin, et al.
Oncology Reports|July 23, 2021
[Corrigendum] HORMAD1 promotes docetaxel resistance in triple negative breast cancer by enhancing DNA damage toleranceBeige Zong, Lu Sun, Yang Peng, et al.
Frontiers in Medicine|January 22, 2024
A case report of a giant ileocecal cystic prolapse through the anus and literature reviewBeige Zong, Xia Xiao, Nijiao Deng, et al.
Clinical Nephrology|November 9, 2017
Endemic influences of political regimes, healthcare systems, and preferences on the frequencies and incidences of nephropathies in eastern Saxony, Germany
Sam Sedaghat, Eleène Sahmila Heshmati, Thomas Frese, et al.
International Journal of Oncology|April 23, 2020
Although c‑MYC contributes to tamoxifen resistance, it improves cisplatin sensitivity in ER‑positive breast cancerRui Chen, Shipeng Guo, Chengcheng Yang, et al.
Oncology Reports|May 26, 2021
HORMAD1 promotes docetaxel resistance in triple negative breast cancer by enhancing DNA damage toleranceBeige Zong, Lu Sun, Yang Peng, et al.
Journal of the American Society of Nephrology : JASN|July 1, 2024
Dialysate Sodium and Mortality: 140 mmol/L at Hemodialysis Initiation by Default?Manfred Hecking, Angelo Karaboyas, Simon Krenn, et al.
Anticancer Research|December 1, 2022
Efficacy of Chemotherapy Plus Bevacizumab in Recurrent Glioblastoma Multiform: A Real-life StudyAlexandre Beige, François Ghiringhelli, Julie Lecuelle, et al.
Archives of Iranian Medicine|July 1, 2021
Efficacy and Safety of Tofacitinib for Treatment of Moderate to Severe Active Ulcerative Colitis: First Report from IranMaryam Jameshorani, Homayoon Vahedi, Anahita Sadeghi, et al.
Cancer Biology & Therapy|November 6, 2019
Low pretreatment lymphocyte/monocyte ratio is associated with the better efficacy of neoadjuvant chemotherapy in breast cancer patientsYang Peng, Rui Chen, Fanli Qu, et al.
Pageof 20